IKON is a 100% allograft matrix from MTF Biologics, designed to align with your goal of optimizing incisions and supporting sternal closure in cardiac surgery. IKON’s gentle processing retains growth factors that support incisional management, aiming to reduce bioburden and inflammation while restoring blood supply.
Sustained Inhibition of Bacterial Growth Over Time Upon Exposure to IKON
In-vitro functional assays have demonstrated IKON’s potential to diminish bacterial growth, achieving a 4 to 5 log reduction versus both gram positive and gram negative pathogens.
Access the IKONAnti-microbial, Anti-inflammatory White Paper Here